[1] 徐婷, 刘彤. 唐氏综合征产前筛查研究进展[J]. 中国实用妇科与产科杂志, 2019, 35(2): 247.
[2] 郭延清. 唐氏综合征及孕中期血清学筛查探讨[J]. 生物学教学, 2015, 40(8): 63.
[3] 杨岚, 唐叶, 郭彩琴, 等. 产前诊断与血清学筛查在高龄孕妇唐氏综合征中的应用比较[J]. 南京医科大学学报(自然科学版), 2015, 35(3): 414.
[4] PITKANENS, LAITINEN P, YLA-OUTINEN A, et al. Extremely large nuchal translucency measurement predicts adverse pregnancy outcome[J]. J Obstet Gynaecol, 2015, 35(1): 22. doi: 10.3109/01443615.2014.935713
[5] IUCULANO A, MURGIA F, PEDDES C, et ak. Metabolic characterization of amniotic fluids of fetuses with enlarged nuchal translucency[J]. J Perinat Med, 2019, 47(3): 311. doi: 10.1515/jpm-2018-0314
[6] 朱继红, 文珂. 胎儿鼻骨、颈项透明层厚度与母体血清学检测联合筛查唐氏综合征[J]. 中国现代医学杂志, 2016, 26(22): 50.
[7] HOLZER I, HUSSLEIN PW, BETTELHEIM D, et al. Value of increased nuchal translucency in the era of noninvasive prenatal testing with cell-free DNA[J]. Int J Gynaecol Obstet, 2019, 145(3): 319. doi: 10.1002/ijgo.12808
[8] 朱继红, 陈英红, 文珂, 等. 超声测量胎儿颈项透明层厚度与孕中期母体血清学检测筛查唐氏综合征[J]. 重庆医学, 2015, 44(17): 2381. doi: 10.3969/j.issn.1671-8348.2015.17.027
[9] 杨苑香, 曾敏, 何倩云, 等. 189例唐氏综合征产前超声表现的临床特征[J]. 现代妇产科进展, 2018, 27(3): 182.
[10] TANAC, WANAPIRAKC, SIRICHOTIYAKULS, et al. How to correct the impact of ethnicity on effectiveness of the second trimester maternal serum screen of fetal Down syndrome?[J]. J Matern Fetal Neonatal Med, 2019, 32(20): 3343. doi: 10.1080/14767058.2018.1463367
[11] CHAKSUWAT P, SIRICHOTIYAKUL S, LUEWAN S, et al. Evaluating the agreement of risk categorization for fetal down syndrome screening between ultrasound-based gestational age and menstrual-based gestational age by maternal serum markers[J]. Obstet Gynecol Int, 2018, 2018: 9687042.
[12] 杨岚, 石锦平, 吴晓, 等. 早孕期血清PAPP-A检测联合中孕期血清AFP、free β-HCG、uE3检测对DS、ES的筛查效果[J]. 山东医药, 2017, 57(35): 18.
[13] 汤瑾, 何松, 魏丽平. 血清PAPP-A、ADAM12-S、β-HCG及孕酮水平与胚胎停止发育的关系研究[J]. 临床和实验医学杂志, 2019, 18(7): 756.
[14] 刘新, 汪越君, 迟建秀. B超检测NT联合血清PIGF、free β-hCG及ADAM12对唐氏综合征的预测价值[J]. 中国妇幼保健, 2018, 33(20): 4689.
[15] ZIOLKOWSKA K, DYDOWICZ P, SOBKOWSKI M, et al. The clinical usefulness of biochemical(free β-hCg, PaPP-a)and ultrasound(nuchal translucency)parameters in prenatal screening of trisomy 21 in the first trimester of pregnancy[J]. Ginekol Pol, 2019, 90(3): 161.